Answers are grounded in this paper and cite their sources.
Crohn's disease (CD) is rapidly increasing in children so an up to date knowledge of diagnosis, investigation and management is essential. Exclusive enteral nutrition is the first line treatment for active disease. The vast majority of children will need immunosuppressant treatment and around 20% will need treatment with biologics. Recent guidelines have helped make best use of available therapies.
No takes yet. Share an insight, caveat, or question.
Kammermeier et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: